Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea after stopping Wegovy is more common than many people expect — and it tends to ease within days rather than weeks. Semaglutide slows how quickly the stomach empties, and when that effect lifts, your gut adjusts. For most people the transition is mild and short-lived, though the experience does vary. These are prescription-only medicines, and a GPhC-registered prescriber is the right person to talk to if your symptoms feel out of the ordinary or are lasting longer than you'd expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works partly by slowing gastric emptying, food lingers longer in the stomach, which reduces hunger signals and helps you feel full. The NHS patient information for semaglutide describes this mechanism alongside the GLP-1 receptor activity that drives it. When you stop injecting, semaglutide's half-life means the drug clears gradually over roughly five to seven days, and your stomach's natural pace begins to return.
That shift is what produces post-stopping nausea for some people. The digestive system had been working at a slower rhythm for weeks or months; returning to a faster tempo can produce queasiness, bloating, or a feeling of things moving through too quickly. It is the same underlying biology that causes nausea in the first days of starting treatment, just in reverse. Our broader overview of Wegovy side effects covers the full gastrointestinal picture if you want the wider context.
Appetite often returns more quickly than people anticipate, and that sudden hunger can itself feel unsettling after months of reduced interest in food. Eating smaller, lower-fat meals and keeping well hydrated during this window gives the gut an easier job as it recalibrates. Keep something bland and easy to digest on hand, plain crackers pulled from the kitchen cupboard tend to work better than skipping meals entirely.
For most people, nausea after stopping Wegovy is genuinely short-lived. The majority of post-stopping GI symptoms resolve within a few days to a week. A smaller number of people notice milder queasiness stretching to two weeks, particularly if they were on a higher maintenance dose and stopped abruptly rather than tapering.
If you are still feeling persistently nauseated after two weeks, or if the nausea is stopping you from eating or drinking normally, that is worth raising with a clinician. There is a fuller look at how long nausea after stopping Wegovy typically lasts (including what the clinical data suggests about duration) if you want more detail on timelines.
Diarrhoea and changes in bowel habit can accompany the nausea during this period too. The same gut-speed recalibration that causes queasiness can shift stool consistency and frequency. If loose stools are part of your picture, what to expect with diarrhoea after stopping Wegovy addresses that specifically. Staying hydrated is especially important if both symptoms appear together.
Most post-stopping nausea is uncomfortable rather than dangerous. There are, however, situations where symptoms need prompt medical attention rather than watchful waiting.
Seek help the same day (or call 999 if severe) if you experience any of the following: intense stomach pain that radiates to your back (with or without vomiting), signs of dehydration such as very dark urine, dizziness or an inability to keep fluids down, or an allergic reaction such as swelling of the face or throat. The MHRA's January 2026 Drug Safety Update specifically highlighted acute pancreatitis as a known, though uncommon, effect associated with GLP-1 medicines; the key symptom is severe and persistent abdominal pain reaching the back. This risk does not disappear the instant you stop the injection, if it develops in the days after your last dose, treat it as urgent.
Less urgent but still worth a GP call: nausea lasting beyond two weeks, any vomiting that prevents normal hydration, or symptoms that are getting worse rather than easing. You can also report unexpected post-stopping symptoms through the MHRA Yellow Card scheme, which helps regulators build a fuller picture of how these medicines behave in real-world use. A full account of what to watch for across all stopping-related effects is on our page about side effects of Wegovy after stopping.
Whether you are pausing treatment, finishing a clinical course, or considering a switch, the decision to stop semaglutide ideally happens in conversation with whoever prescribed it. Tapering the dose before stopping (rather than going straight from maintenance to nothing) is one approach prescribers sometimes recommend to reduce the sharpness of the gut's adjustment, though whether this is appropriate depends on your individual clinical picture.
It is also worth knowing that for some people, nausea on stopping is tied to appetite returning, and that returning appetite can make the post-treatment period challenging. That is a normal biological response to the drug leaving the system, not a sign of willpower failing. Our full Wegovy guide covers the treatment's mechanism and what ongoing clinical support looks like. If cost has been a factor in stopping, a plain account of how Wegovy pricing works in the UK may be useful context before making a final decision.
At nume, every consultation (including conversations about stopping or restarting) is reviewed by a real prescriber, not automated software. If you are weighing up next steps, checking your eligibility takes a few minutes and puts you in front of a clinician the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.